Posts in category Healthcare


Stock Update (NASDAQ:CLRB): Here’s Why Cellectar Biosciences Inc Shares Are Rising 15%

Cellectar Biosciences Inc (NASDAQ:CLRB) investors cheer the news that the United States Patent and Trademark Office …

Read more

Here’s Why Cascadian Therapeutics Inc (USA) (CASC) Shares Tumble 11%

Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) announced that it intends to offer and sell shares of …

Read more

Company Update (NASDAQ:ENDP): Endo International plc – Ordinary Shares Announces Agreement to Resolve Federal Trade Commission Investigation and Litigation

Endo International plc – Ordinary Shares (NASDAQ:ENDP) and the U.S. Federal Trade Commission (FTC) filed …

Read more

Company Update (NASDAQ:ETRM): EnteroMedics Inc Announces Closing of $19.0 Million Underwritten Public Offering and Full Exercise of Over-allotment Option

EnteroMedics Inc (NASDAQ:ETRM) announced the closing of an underwritten public offering of units for gross …

Read more

Stock Update (NYSEMKT:RNN): Rexahn Pharmaceuticals, Inc. Provides Update on Anti-Cancer Investigational Drug Candidate RX-3117

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) announced an update on the safety and efficacy of RX-3117 in …

Read more

Here’s Why Bellerophon Therapeutics Inc (BLPH) Stock Rose 16% Today

Bellerophon Therapeutics Inc (NASDAQ:BLPH) investors got some support today from H.C. Wainwright analyst Andrew Fein, which initiated a …

Read more

Company Update (NASDAQ:GILD): Gilead Sciences, Inc. Announces EMA Validation of Marketing Authorization Application for Investigational Chronic

Gilead Sciences, Inc. (NASDAQ:GILD) announced that the company’s Marketing Authorization Application (MAA) for the investigational, …

Read more

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces Debt Restructuring and Related Private Placement of Exchangeable Senior Notes

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that it and its wholly owned subsidiary, Corsicanto II …

Read more

Company Update (NASDAQ:SGYP): Synergy Pharmaceuticals Inc Announces FDA Approval for TRULANCE to Treat Adults with CIC

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced that the U.S. Food and Drug Administration (FDA) has approved …

Read more

Company Update (NASDAQ:NVAX): Novavax, Inc. Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults

Novavax, Inc. (NASDAQ:NVAX) announced the initiation of a Phase 2 clinical trial of its respiratory …

Read more